Bio

Andrew Rymer is a Partner in Centerview’s healthcare investment banking team. He brings over 20 years of experience, advising companies on a variety of strategic matters. Mr. Rymer has established himself as one the leading healthcare advisors, having worked on some of the industry’s largest and most important transactions. These include: Pfizer’s $68 billion acquisition of Wyeth; Johnson & Johnson’s $21bn acquisition of Synthes; Pfizer’s $14bn acquisition of Medivation and $5.2bn acquisition of Anacor; athenahealth’s $5.7bn sale to Veritas Capital and Evergreen Coast Capital; Merck’s €3.25 bn acquisition of Antelliq Group; Kohlberg and Mubadala’s approximately $3 bn acquisition of PCI Pharma Services; Endocyte’s $2.1bn sale to Novartis; Catalent’s $1.2bn acquisition of Paragon Bioservices; Micromet’s $1.2 billion sale to Amgen; NeuroDerm’s $1.1bn sale to Mitsubishi Tanabe; inVentiv’s $1.1 billion sale to TH Lee; Novartis’s $1bn sale of its Sandoz US dermatology and generics business to Aurobindo; Nightstar Therapeutics’ $877mm sale to Biogen; Pfizer’s joint venture with GlaxoSmithKline to create the world’s leading consumer healthcare company; Merck’s worldwide strategic collaboration with Eisai regarding Lenvima; Phillip-Medisize’s sale to Golden Gate Capital; and US Renal’s sale to Leonard Green. Additionally, Mr. Rymer has executed numerous financing transactions and advisory assignments for a diverse group of industry leaders including Pfizer, Johnson & Johnson, Eli Lilly, Aetna, Wellchoice, Horizon Blue Cross Blue Shield and many of the largest financial sponsors. Prior to joining Centerview, Mr. Rymer spent 10 years at Goldman Sachs, most recently as a Managing Director with responsibility for the firm’s Healthcare M&A activities. While at Goldman Sachs, he was asked by the firm’s CEO and President to serve as Head of Client Strategy for 18 months in order to help enhance effectiveness across Goldman’s client footprint. Mr. Rymer began his career as an investment banking analyst at Donaldson, Lufkin & Jenrette and worked at Credit Suisse upon its acquisition of DLJ. Mr. Rymer received a B.A., cum laude and with Honors, from Dartmouth College.